Update shared on 18 Nov 2025
Fair value Increased 3.76%Analysts have raised their fair value estimate for Acutaas Chemicals from $1,765.17 to $1,831.50. This change reflects updated evaluations of future performance and risk factors.
What's in the News
- A board meeting is scheduled for October 17, 2025, to approve the unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2025 (Key Developments).
- A board meeting was held on August 29, 2025, to consider and approve the notice convening the 18th annual general meeting, which is scheduled for September 25, 2025 (Key Developments).
- The re-appointment of Mr. Nareshkumar Ramjibhai Patel as managing director and executive chairman for a new five-year term will be considered, subject to shareholder approval at the upcoming annual general meeting (Key Developments).
Valuation Changes
- The Fair Value Estimate has risen from ₹1,765.17 to ₹1,831.50.
- The Discount Rate has increased slightly from 12.73% to 12.76%.
- The Revenue Growth projection remains virtually unchanged at approximately 33.16%.
- The Net Profit Margin shows negligible change, staying near 23.44%.
- The future P/E ratio has risen from 37.07x to 38.93x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.